Molecular formula: | C23H20N6O |
Average mass: | 396.454 |
Monoisotopic mass: | 396.169859 |
ChemSpider ID: | 71117518 |
1 of 1 defined stereocentres
(S)-N-(4-Amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl)acrylamide
1661854-97-2
[RN]2-Propenamide, N-[(8S)-4-amino-8,9-dihydro-6-methyl-5-(3-quinolinyl)pyrimido[5,4-b]indolizin-8-yl]-
[ACD/Index Name]N-[(8S)-4-Amino-5-(3-chinolinyl)-6-methyl-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]acrylamid
[German]
[ACD/IUPAC Name]N-[(8S)-4-Amino-6-méthyl-5-(3-quinoléinyl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]acrylamide
[French]
[ACD/IUPAC Name]N-[(8S)-4-Amino-6-methyl-5-(3-quinolinyl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]acrylamide
[ACD/IUPAC Name]N-[(8S)-4-amino-6-methyl-5-(quinolin-3-yl)-8H,9H-pyrimido[5,4-b]indolizin-8-yl]prop-2-enamide
EGFR_HUMAN
Epidermal growth factor receptor
MFCD31715430
[MDL number]N-[(8S)-4-amino-6-methyl-5-quinolin-3-yl-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide
N-[(8S)-4-amino-8,9-dihydro-6-methyl-5-(3-quinolinyl)pyrimido[5,4-b]indolizin-8-yl]-2-propenamide
Zipalertinib